Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality-Reference-Cited by-同舟云学术

Inversion 3 Cytogenetic Abnormality in an Allogeneic Hematopoietic Cell Transplant Recipient Representative of a Donor-Derived Constitutional Abnormality

Published:2017-09 Issue:9 Volume:23 Page:1582-1587
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Dias Ajoy^ORCID,Al-Kali Aref,Van Dyke Daniel,Niederwieser Dietger,Vucinic Vladan,Lemke Johannes,Muller Christel,Schwind Sebastian,Teichmann Anne-Christin,Bakken Ruth,Burns Linda J.,Litzow Mark^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference27 articles.

1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe;Urbano-Ispizua;Bone Marrow Transplant,2002

2. Hematopoietic stem cell transplantation for hematological malignancies in Europe;Gratwohl;Leukemia,2003

3. Hematopoietic-cell transplantation at 50;Appelbaum;N Engl J Med,2007

4. Management of autoimmune diseases after haematopoietic stem cell transplantation;Holbro;Br J Haematol,2012

5. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features;Cancers;2023-01-11

2. Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure;Transplantation and Cellular Therapy;2022-07

3. Clonal dynamics of donor-derived myelodysplastic syndrome after unrelated hematopoietic cell transplantation for high-risk pediatric B-lymphoblastic leukemia;Molecular Case Studies;2018-06-11